Are adverse effects incorporated in economic models? An initial review of current practice
Craig D, McDaid C, Fonseca T, Stock C, Duffy S, Woolacott N
Record ID 32007000887
English
Authors' recommendations:
Study found that there is an implicit assumption within modelling guidance that adverse effects are very important. There is a need for clearer and more explicit reporting of adverse effects, or their exclusion, in decision models
Details
Project Status:
Completed
URL for project:
http://www.hta.ac.uk/1676
Year Published:
2009
English language abstract:
An English language summary is available
Publication Type:
Not Assigned
Country:
England, United Kingdom
MeSH Terms
- Models, Economic
- Adverse Drug Reaction Reporting Systems
- Costs and Cost Analysis
- Pharmaceutical Preparations
Contact
Organisation Name:
NIHR Health Technology Assessment programme
Contact Address:
NIHR Journals Library, National Institute for Health and Care Research, Evaluation, Trials and Studies Coordinating Centre, Alpha House, University of Southampton Science Park, Southampton SO16 7NS, UK
Contact Name:
journals.library@nihr.ac.uk
Contact Email:
journals.library@nihr.ac.uk
Copyright:
2009 Queen's Printer and Controller of HMSO
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.